Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
03/2014
03/05/2014CN103610672A Application of Hippolachnin A in medicament for treating or preventing chronic heart failure
03/05/2014CN103610650A Isosorbide mononitrate sustained-release pallets, preparation prepared from same and preparation method for isosorbide mononitrate sustained-release pallets
03/05/2014CN103610643A Preparation method of lipidosome applicable to water-soluble anthraquinone medicament
03/05/2014CN103610640A Alprostadil medium-and-long-chain lipid emulsion for injection and preparation method thereof
03/05/2014CN103610118A Sea cucumber nutritional oral liquid and application method thereof
03/05/2014CN103610117A Sea cucumber nutritional oral liquid
03/05/2014CN103610115A Blood-sugar-reducing sea cucumber oral liquid and application method thereof
03/05/2014CN103610113A Blood-pressure-reducing sea cucumber oral liquid and application method thereof
03/05/2014CN103610075A Sea cucumber oral liquid
03/05/2014CN103610072A Preparation method for blood-sugar-reducing sea cucumber oral liquid
03/05/2014CN103610070A Blood-fat-reducing sea cucumber oral liquid and application method thereof
03/05/2014CN103610068A Preparation method for blood-fat-reducing sea cucumber oral liquid
03/05/2014CN103609771A Antihypertensive healthcare tea
03/05/2014CN103609765A Bagged preparation for preventing and treating hypertension disease
03/05/2014CN103006842B Drug for treatment of traditional Chinese medicine chest stuffiness and pains
03/05/2014CN102949648B Traditional Chinese medicine for treating traumatic injury
03/05/2014CN102920736B Preparation method of traditional Chinese medicine leech extract
03/05/2014CN102894152B Health-care tea and preparation method thereof
03/05/2014CN102772747B Traditional Chinese medicine preparation for treating heat-toxicity heart-disoperation type viral myocarditis
03/05/2014CN102772551B Antihypertensive drug composition, preparation method of antihypertensive drug composition and antihypertensive device using antihypertensive drug composition
03/05/2014CN102716202B Method for extracting medicine for treating human cardiovascular diseases from thalictrum robustum
03/05/2014CN102698089B Preparation method of ephedrine extract-containing oral solution for preventing and treating cerebral ischemia
03/05/2014CN102697879B Application of Thalictrum robustum Maxim. in extracting drug for treating human cardiovascular diseases
03/05/2014CN102686220B Capsule of complex danshen drop pill
03/05/2014CN102600451B Felodipine ramipril compound sustained-release preparation and preparation method thereof
03/05/2014CN102498091B Glycine compound
03/05/2014CN102242080B Method for treating or diagnosing heart failure or tendency of heart failure or improving functions of myocardial cells by miR-24 (MicroRNA-24)
03/05/2014CN102048677B Valganciclovir Hydrochloride solid preparation and preparation method thereof
03/05/2014CN101884767B Plant extract composite for preventing diabetes complication and senium and preparation method thereof
03/05/2014CN101708274B Quality control method of pill preparation for treating chest impediment and cardialgia
03/05/2014CN101701006B Phenethanolamine derivatives for treatment of respiratory diseases
03/04/2014US8664360 BSL3 polypeptides
03/04/2014US8664216 Spiro-5,6-dihydro-4H-2,3,5,10b-tetraaza-benzo[e]azulenes
03/04/2014US8663693 Nanoparticulate formulations of fenofibrate
03/04/2014US8663652 Regeneration of endogenous myocardial tissue
03/04/2014US8663629 Kallikrein-binding “kunitz domain” proteins and analogues thereof
03/04/2014US8661630 Coating comprising an amorphous primer layer and a semi-crystalline reservoir layer
03/04/2014CA2526490C Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
03/04/2014CA2444164C Pufa polyketide synthase systems and uses thereof
02/2014
02/27/2014WO2014031649A1 Compositions and methods for treating or preventing anthracycline induced cardiotoxicity
02/27/2014WO2014030977A1 Pharmaceutical composition comprising, as active ingredients, peptides which exhibit inhibitory activity against angiotensin-i converting enzyme for preventing or treating cardiovascular diseases
02/27/2014WO2014030743A1 Heterocycic compound
02/27/2014WO2014030731A1 Method for producing polyphenol composition
02/27/2014WO2014030716A1 Pyrazolopyrimidine compound
02/27/2014WO2014029984A1 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
02/27/2014WO2014029983A1 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
02/27/2014WO2014029333A1 Substituted oxazolidinone compound and pharmaceutical composition comprising the compound and use thereof
02/27/2014WO2014029197A1 3h-1,2-dithiocyclopentene-3-thioketone compounds and application thereof
02/27/2014WO2014008374A3 Combination therapies comprising metformin salts and antihyperglycemia agents or antihyperlipidemia agents
02/27/2014WO2013192556A3 Salt crystals
02/27/2014WO2013190520A3 Gh-releasing agents in the treatment of vascular stenosis and associated conditions
02/27/2014US20140057995 Aqueous-lipidic carotenoid-containing compositions
02/27/2014US20140057869 Novel Pharmaceutical Agents Containing Carbohydrate Moieties And Methods Of Their Preparation And Use
02/27/2014US20140056974 Spontaneously Dispersible N-Benzoyl Staurosporine Compositions
02/27/2014US20140056809 Treatment and diagnosis of macrophage mediated disease
02/27/2014DE60000133C5 Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen Essential fatty acids for the prevention of cardiovascular attacks
02/26/2014EP2700643A1 Tetrahydrothiazepine derivative
02/26/2014EP2700627A1 Method for producing complex crystal and method for screening complex crystal
02/26/2014EP2699578A1 Fluoroalkyl-substituted pyrazolopyridines and use thereof
02/26/2014EP2699573A2 7-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1h-imidazo[4,5-c]quinoline derivatives
02/26/2014EP2699572A1 Heterocyclic compounds as kinase inhibitors
02/26/2014EP2699560A2 5-carbamoyl-adamantan-2-yl amide derivatives, pharmaceutically acceptable salts thereof and preparation process thereof
02/26/2014EP2699552A1 Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
02/26/2014EP2699539A2 Cyclopropyl derivatives and methods of use
02/26/2014EP2699251A1 Infant formula for use in the prevention of cardiovascular diseases
02/26/2014EP2699243A1 Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage
02/26/2014CN103608347A 咪唑并吡啶化合物 Imidazopyridine compound
02/26/2014CN103608346A Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase
02/26/2014CN103608326A Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease
02/26/2014CN103608011A Methods and compositions suitable for preventing and treating hyperleptinemia
02/26/2014CN103602590A Method of preparing functional monascus mycelia and fermentation liquor by liquid fermentation, and products of the monascus mycelia and the fermentation liquor
02/26/2014CN103602568A Medicinal wine
02/26/2014CN103602555A Gynostemma pentaphylla compound fermented healthcare wine and production technology thereof
02/26/2014CN103602552A Compound fermentation white atractylodes rhizome health-care wine and production technology thereof
02/26/2014CN103602539A Preparation method for health beer
02/26/2014CN103601808A Novel natriuretic peptide, preparation method and applications thereof in preparation of genetic engineering drugs
02/26/2014CN103601724A Novel oxazolidinone compound, as well as preparation method and application thereof
02/26/2014CN103601709A Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
02/26/2014CN103601670A Piplartine analogue, and preparation method and application thereof
02/26/2014CN103599540A Pharmaceutical composition containing glinides and vitamin B, and use of pharmaceutical composition
02/26/2014CN103599539A Combination therapy comprising SGLT inhibitor and DPP4 inhibitor
02/26/2014CN103599537A Pharmaceutical composition of calcium channel blocker/thiazide diuretic/5-methyltetrahydrofolate
02/26/2014CN103599535A External ointment prepared from i26 immune egg powder and traditional Chinese medicine decoction
02/26/2014CN103599523A Application of pentapeptide metabolite in preparation of anti-inflammatory medicine
02/26/2014CN103599509A Traditional Chinese medicine composition for treating typhoid floating Yang
02/26/2014CN103599485A Traditional Chinese medicine composition for treating premature beat
02/26/2014CN103599483A Traditional Chinese medicine formula for treating coronary heart disease
02/26/2014CN103599479A Traditional Chinese medicine for treating hepatic and renal yin deficiency type cerebral apoplexy
02/26/2014CN103599476A Traditional Chinese medicine formula for treatment of hypertension with hyperlipidemia
02/26/2014CN103599473A Traditional Chinese medicinal composition for treating dizziness and chest distress
02/26/2014CN103599457A Traditional Chinese medicine formula for treating heart disease
02/26/2014CN103599456A Traditional Chinese medicinal composition for treating cerebral thrombus
02/26/2014CN103599454A Traditional Chinese medicine for treating arteriosclerosis
02/26/2014CN103599431A Traditional Chinese medicine formula for treating cardiac asthma
02/26/2014CN103599422A Mulberry lotus polygonatum-odoratum tea and preparation method thereof
02/26/2014CN103599396A Traditional Chinese medicine formula for treatment of hypertension
02/26/2014CN103599394A Traditional Chinese medicine for treating hypertension
02/26/2014CN103599368A Traditional Chinese medicinal preparation for treating menopause hypertension
02/26/2014CN103599340A Pharmaceutical composition used for treating and preventing diabetes and eye complications thereof, and applications of the pharmaceutical composition
02/26/2014CN103599297A Medicament for treating qi deficiency and blood stasis-induced ischemic stroke
1 ... 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 ... 1595